PD-1 regulates KLRG1+ group 2 innate lymphoid cells

Journal of Experimental Medicine

Volumn 214, Issue 6, 2017, Pages 1663-1678

  Taylor, Samuel ^a   Huang, Yuefeng ^b   Mallett, Grace ^d   Stathopoulou, Chaido ^d   Felizardo, Tania C ^a   Sun, Ming An ^c   Martin, Evelyn L ^d   Zhu, Nathaniel ^a   Woodward, Emma L ^d   Elias, Martina S ^d   Scott, Jonathan ^d   Reynolds, Nick J ^d,e   Paul, William E ^b   Fowler, Daniel H ^a   Amarnath, Shoba ^d  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH AND HUMAN DEVELOPMENT   (United States)

^d NEWCASTLE UNIVERSITY   (United Kingdom)

^e ROYAL VICTORIA INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PROGRAMMED DEATH 1 LIGAND 1; PROTEIN DERIVATIVE; PROTEIN KLRG1; STAT5 PROTEIN; UNCLASSIFIED DRUG; HOMEODOMAIN PROTEIN; IMMUNOGLOBULIN RECEPTOR; KLRG1 PROTEIN, HUMAN; KLRG1 PROTEIN, MOUSE; LECTIN; PDCD1 PROTEIN, HUMAN; PDCD1 PROTEIN, MOUSE; PROGRAMMED DEATH 1 RECEPTOR; RAG-1 PROTEIN; TRANSACTIVATOR PROTEIN;

ADOPTIVE TRANSFER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; EFFECTOR CELL; GENE EXPRESSION; HUMAN; HUMAN CELL; IMMUNE RESPONSE; LYMPHOID CELL; MOUSE; NIPPOSTRONGYLUS BRASILIENSIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; ANIMAL; C57BL MOUSE; DEFICIENCY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBPOPULATION; METABOLISM; NIPPOSTRONGYLUS; PARASITE; PATHOLOGY; PHYSIOLOGY; STRONGYLE INFECTION;

ANIMALS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HOMEODOMAIN PROTEINS; HUMANS; IMMUNITY, INNATE; LECTINS, C-TYPE; LYMPHOCYTE COUNT; LYMPHOCYTE SUBSETS; LYMPHOCYTES; MICE, INBRED C57BL; NIPPOSTRONGYLUS; PARASITES; PROGRAMMED CELL DEATH 1 RECEPTOR; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; STAT5 TRANSCRIPTION FACTOR; STRONGYLIDA INFECTIONS; TRANS-ACTIVATORS;

EID: 85021856633     PISSN: 00221007     EISSN: 15409538     Source Type: Journal    
DOI: 10.1084/jem.20161653     Document Type: Article

References (62)

1. Agata, Y., A. Kawasaki, H. Nishimura, Y. Ishida, T. Tsubata, H. Yagita, and T. Honjo. 1996. Expression of the PD-1 antigen on the surface of stimulated mouse T and B lymphocytes. Int. Immunol. 8:765-772. http ://dx .doi .org/10 .1093/intimm/8 .5 .765
2. Amarnath, S., C.M. Costanzo, J. Mariotti, J.L. Ullman, W.G. Telford, V. Kapoor, J.L. Riley, B.L. Levine, C.H. June, T. Fong, et al. 2010. Regulatory T cells and human myeloid dendritic cells promote tolerance via programmed death ligand-1. PLoS Biol. 8:e1000302. http ://dx .doi .org/10 .1371/journal .pbio .1000302
3. Amarnath, S., C.W. Mangus, J.C. Wang, F. Wei, A. He, V. Kapoor, J.E. Foley, P.R. Massey, T.C. Felizardo, J.L. Riley, et al. 2011. The PDL1-PD1 axis converts human TH1 cells into regulatory T cells. Sci. Transl. Med. 3:111ra120. http ://dx .doi .org/10 .1126/scitranslmed .3003130
4. + regulatory T cells and IL-10. J. Immunol. 171:971-978. http ://dx .doi .org/10 .4049/jimmunol .171 .2 .971
5. Barber, D.L., E.J. Wherry, D. Masopust, B. Zhu, J.P. Allison, A.H. Sharpe, G.J. Freeman, and R. Ahmed. 2006. Restoring function in exhausted CD8 T cells during chronic viral infection. Nature. 439:682-687. http ://dx .doi .org/10 .1038/nature04444
6. Barber, D.L., K.D. Mayer-Barber, C.G. Feng, A.H. Sharpe, and A. Sher. 2011. CD4 T cells promote rather than control tuberculosis in the absence of PD-1-mediated inhibition. J. Immunol. 186:1598-1607. http ://dx .doi .org/10 .4049/jimmunol .1003304
7. Barlow, J.L., A. Bellosi, C.S. Hardman, L.F. Drynan, S.H. Wong, J.P. Cruickshank, and A.N. McKenzie. 2012. Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity. J. Allergy Clin. Immunol. 129:191-8.e1: 4. http ://dx .doi .org/10 .1016/j .jaci .2011 .09 .041
8. Barlow, J.L., S. Peel, J. Fox, V. Panova, C.S. Hardman, A. Camelo, C. Bucks, X. Wu, C.M. Kane, D.R. Neill, et al. 2013. IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction. J. Allergy Clin. Immunol. 132:933-941. http ://dx .doi .org/10 .1016/j .jaci .2013 .05 .012
9. + CD44(hi) lymphoid cells mediate innate type 2 immunity and allergic inflammation in the lungs. J. Immunol. 188:1503-1513. http ://dx .doi .org/10 .4049/jimmunol .1102832
10. Bashi, T., G. Bizzaro, D. Ben-Ami Shor, M. Blank, and Y. Shoenfeld. 2015. The mechanisms behind helminth's immunomodulation in autoimmunity. Autoimmun. Rev. 14:98-104. http ://dx .doi .org/10 .1016/j .autrev .2014 .10 .004
11. + regulatory T cells. Infect. Immun. 75:4334-4341. http ://dx .doi .org/10 .1128/IAI .00553-07
12. Bourgon, R., R. Gentleman, and W. Huber. 2010. Independent filtering increases detection power for high-throughput experiments. Proc. Natl. Acad. Sci. USA. 107:9546-9551. http ://dx .doi .org/10 .1073/pnas .0914005107
13. Brestoff, J.R., B.S. Kim, S.A. Saenz, R.R. Stine, L.A. Monticelli, G.F. Sonnenberg, J.J. Thome, D.L. Farber, K. Lutfy, P. Seale, and D. Artis. 2015. Group 2 innate lymphoid cells promote beiging of white adipose tissue and limit obesity. Nature. 519:242-246. http ://dx .doi .org/10 .1038/nature14115
14. Carvalho, B.S., and R.A. Irizarry. 2010. A framework for oligonucleotide microarray preprocessing. Bioinformatics. 26:2363-2367. http ://dx .doi .org/10 .1093/bioinformatics/btq431
15. Chang, Y.J., H.Y. Kim, L.A. Albacker, N. Baumgarth, A.N. McKenzie, D.E. Smith, R.H. Dekruyff, and D.T. Umetsu. 2011. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat. Immunol. 12:631-638. http ://dx .doi .org/10 .1038/ni .2045
16. Das, S., G. Suarez, E.J. Beswick, J.C. Sierra, D.Y. Graham, and V.E. Reyes. 2006. Expression of B7-H1 on gastric epithelial cells: its potential role in regulating T cells during Helicobacter pylori infection. J. Immunol. 176:3000-3009. http ://dx .doi .org/10 .4049/jimmunol .176 .5 .3000
17. Day, C.L., D.E. Kaufmann, P. Kiepiela, J.A. Brown, E.S. Moodley, S. Reddy, E.W. Mackey, J.D. Miller, A.J. Leslie, C. DePierres, et al. 2006. PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression. Nature. 443:350-354. http ://dx .doi .org/10 .1038/nature05115
18. Dong, H., G. Zhu, K. Tamada, and L. Chen. 1999. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat. Med. 5:1365-1369. http ://dx .doi .org/10 .1038/70932
19. Duraiswamy, J., C.C. Ibegbu, D. Masopust, J.D. Miller, K. Araki, G.H. Doho, P. Tata, S. Gupta, M.J. Zilliox, H.I. Nakaya, et al. 2011. Phenotype, function, and gene expression profiles of programmed death-1(hi) CD8 T cells in healthy human adults. J. Immunol. 186:4200-4212. http ://dx .doi .org/10 .4049/jimmunol .1001783
20. Fallon, P.G., S.J. Ballantyne, N.E. Mangan, J.L. Barlow, A. Dasvarma, D.R. Hewett, A. McIlgorm, H.E. Jolin, and A.N. McKenzie. 2006. Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion. J. Exp. Med. 203:1105-1116. http ://dx .doi .org/10 .1084/jem .20051615
21. Fife, B.T., K.E. Pauken, T.N. Eagar, T. Obu, J. Wu, Q. Tang, M. Azuma, M.F. Krummel, and J.A. Bluestone. 2009. Interactions between PD-1 and PD-L1 promote tolerance by blocking the TCR-induced stop signal. Nat. Immunol. 10:1185-1192. http ://dx .doi .org/10 .1038/ni .1790
22. + Tregs by limiting STAT-5 phosphorylation in patients chronically infected with HCV. J. Clin. Invest. 119:551-564. http ://dx .doi .org/10 .1172/JCI36604
23. Francisco, L.M., V.H. Salinas, K.E. Brown, V.K. Vanguri, G.J. Freeman, V.K. Kuchroo, and A.H. Sharpe. 2009. PD-L1 regulates the development, maintenance, and function of induced regulatory T cells. J. Exp. Med. 206:3015-3029. http ://dx .doi .org/10 .1084/jem .20090847
24. Halim, T.Y., A. MacLaren, M.T. Romanish, M.J. Gold, K.M. McNagny, and F. Takei. 2012. Retinoic-acid-receptor-related orphan nuclear receptor alpha is required for natural helper cell development and allergic inflammation. Immunity. 37:463-474. http ://dx .doi .org/10 .1016/j .immuni .2012 .06 .012
25. Hotez, P.J., P.J. Brindley, J.M. Bethony, C.H. King, E.J. Pearce, and J. Jacobson. 2008. Helminth infections: the great neglected tropical diseases. J. Clin. Invest. 118:1311-1321. http ://dx .doi .org/10 .1172/JCI34261
26. Huang, W., B.T. Sherman, and R.A. Lempicki. 2009. Systematic and integrative analysis of large gene lists using DAV ID bioinformatics resources. Nat. Protoc. 4:44-57. http ://dx .doi .org/10 .1038/nprot .2008 .211
27. Huang, Y., L. Guo, J. Qiu, X. Chen, J. Hu-Li, U. Siebenlist, P.R. Williamson, J.F. Urban Jr., and W.E. Paul. 2015. IL-25-responsive, lineage-negative KLRG1(hi) cells are multipotential 'inflammatory' type 2 innate lymphoid cells. Nat. Immunol. 16:161-169. http ://dx .doi .org/10 .1038/ni .3078
28. Irizarry, R.A., B. Hobbs, F. Collin, Y.D. Beazer-Barclay, K.J. Antonellis, U. Scherf, and T.P. Speed. 2003. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics. 4:249-264. http ://dx .doi .org/10 .1093/biostatistics/4 .2 .249
29. Keir, M.E., M.J. Butte, G.J. Freeman, and A.H. Sharpe. 2008. PD-1 and its ligands in tolerance and immunity. Annu. Rev. Immunol. 26:677-704. http ://dx .doi .org/10 .1146/annurev .immunol .26 .021607 .090331
30. Koyasu, S., K. Moro, M. Tanabe, and T. Takeuchi. 2010. Natural helper cells: a new player in the innate immune response against helminth infection. Adv. Immunol. 108:21-44. http ://dx .doi .org/10 .1016/B978-0-12-380995-7 .00002-1
31. Latchman, Y., C.R. Wood, T. Chernova, D. Chaudhary, M. Borde, I. Chernova, Y. Iwai, A.J. Long, J.A. Brown, R. Nunes, et al. 2001. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat. Immunol. 2:261-268. http ://dx .doi .org/10 .1038/85330
32. Lee, M.W., J.I. Odegaard, L. Mukundan, Y. Qiu, A.B. Molofsky, J.C. Nussbaum, K. Yun, R.M. Locksley, and A. Chawla. 2015. Activated type 2 innate lymphoid cells regulate beige fat biogenesis. Cell. 160:74-87. http ://dx .doi .org/10 .1016/j .cell .2014 .12 .011
33. Maazi, H., N. Patel, I. Sankaranarayanan, Y. Suzuki, D. Rigas, P. Soroosh, G.J. Freeman, A.H. Sharpe, and O. Akbari. 2015. ICOS :ICOS-ligand interaction is required for type 2 innate lymphoid cell function, homeostasis, and induction of airway hyperreactivity. Immunity. 42:538-551. http ://dx .doi .org/10 .1016/j .immuni .2015 .02 .007
34. MacDonald, J.W.2016. mogene20sttranscriptcluster.db: Affymetrix mogene20 annotation data (chip mogene20sttranscriptcluster). R package version 8.5.0. http ://bioconductor .org/packages/clariomdhumanprobeset .db/
35. Molofsky, A.B., F. Van Gool, H.E. Liang, S.J. Van Dyken, J.C. Nussbaum, J. Lee, J.A. Bluestone, and R.M. Locksley. 2015. Interleukin-33 and interferon-γ counter-regulate group 2 innate lymphoid cell activation during immune perturbation. Immunity. 43:161-174. http ://dx .doi .org/10 .1016/j .immuni .2015 .05 .019
36. Monticelli, L.A., G.F. Sonnenberg, M.C. Abt, T. Alenghat, C.G. Ziegler, T.A. Doering, J.M. Angelosanto, B.J. Laidlaw, C.Y. Yang, T. Sathaliyawala, et al. 2011. Innate lymphoid cells promote lung-tissue homeostasis after infection with influenza virus. Nat. Immunol. 12:1045-1054. http ://dx .doi .org/10 .1038/ni .2131
37. Moro, K., T. Yamada, M. Tanabe, T. Takeuchi, T. Ikawa, H. Kawamoto, J. Furusawa, M. Ohtani, H. Fujii, and S. Koyasu. 2010. Innate production of TH2 cytokines by adipose tissue-associated c-Kit+Sca-1+ lymphoid cells. Nature. 463:540-544. http ://dx .doi .org/10 .1038/nature08636
38. Motomura, Y., H. Morita, K. Moro, S. Nakae, D. Artis, T.A. Endo, Y. Kuroki, O. Ohara, S. Koyasu, and M. Kubo. 2014. Basophil-derived interleukin-4 controls the function of natural helper cells, a member of ILC2s, in lung inflammation. Immunity. 40:758-771. http ://dx .doi .org/10 .1016/j .immuni .2014 .04 .013
39. Neill, D.R., S.H. Wong, A. Bellosi, R.J. Flynn, M. Daly, T.K. Langford, C. Bucks, C.M. Kane, P.G. Fallon, R. Pannell, et al. 2010. Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature. 464:1367-1370. http ://dx .doi .org/10 .1038/nature08900
40. Novak, U., A. Mui, A. Miyajima, and L. Paradiso. 1996. Formation of STAT5-containing DNA binding complexes in response to colony-stimulating factor-1 and platelet-derived growth factor. J. Biol. Chem. 271:18350-18354. http ://dx .doi .org/10 .1074/jbc .271 .31 .18350
41. Okazaki, T., A. Maeda, H. Nishimura, T. Kurosaki, and T. Honjo. 2001. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc. Natl. Acad. Sci. USA. 98:13866-13871. http ://dx .doi .org/10 .1073/pnas .231486598
42. Okazaki, T., Y. Iwai, and T. Honjo. 2002. New regulatory co-receptors: inducible co-stimulator and PD-1. Curr. Opin. Immunol. 14:779-782. http ://dx .doi .org/10 .1016/S0952-7915(02)00398-9
43. Paclik, D., C. Stehle, A. Lahmann, A. Hutloff, and C. Romagnani. 2015. ICOS regulates the pool of group 2 innate lymphoid cells under homeostatic and inflammatory conditions in mice. Eur. J. Immunol. 45:2766-2772. http ://dx .doi .org/10 .1002/eji .201545635
44. Parry, R.V., J.M. Chemnitz, K.A. Frauwirth, A.R. Lanfranco, I. Braunstein, S.V. Kobayashi, P.S. Linsley, C.B. Thompson, and J.L. Riley. 2005. CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol. Cell. Biol. 25:9543-9553. http ://dx .doi .org/10 .1128/MCB .25 .21 .9543-9553 .2005
45. Price, A.E., H.E. Liang, B.M. Sullivan, R.L. Reinhardt, C.J. Eisley, D.J. Erle, and R.M. Locksley. 2010. Systemically dispersed innate IL-13-expressing cells in type 2 immunity. Proc. Natl. Acad. Sci. USA. 107:11489-11494. http ://dx .doi .org/10 .1073/pnas .1003988107
46. Rak, G.D., L.C. Osborne, M.C. Siracusa, B.S. Kim, K. Wang, A. Bayat, D. Artis, and S.W. Volk. 2016. IL-33-dependent group 2 innate lymphoid cells promote cutaneous wound healing. J. Invest. Dermatol. 136:487-496. http ://dx .doi .org/10 .1038/JID .2015 .406
47. Ritchie, M.E., B. Phipson, D. Wu, Y. Hu, C.W. Law, W. Shi, and G.K. Smyth. 2015. limma powers differential expression analyses for RNAsequencing and microarray studies. Nucleic Acids Res. 43:e47. http ://dx .doi .org/10 .1093/nar/gkv007
48. Ruyssers, N.E., B.Y. De Winter, J.G. De Man, A. Loukas, M.S. Pearson, J.V. Weinstock, R.M. Van den Bossche, W. Martinet, P.A. Pelckmans, and T.G. Moreels. 2009. Therapeutic potential of helminth soluble proteins in TNBS-induced colitis in mice. Inflamm. Bowel Dis. 15:491-500. http ://dx .doi .org/10 .1002/ibd .20787
49. Salimi, M., J.L. Barlow, S.P. Saunders, L. Xue, D. Gutowska-Owsiak, X. Wang, L.C. Huang, D. Johnson, S.T. Scanlon, A.N. McKenzie, et al. 2013. A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J. Exp. Med. 210:2939-2950. http ://dx .doi .org/10 .1084/jem .20130351
50. Seillet, C., L.A. Mielke, D.B. Amann-Zalcenstein, S. Su, J. Gao, F.F. Almeida, W. Shi, M.E. Ritchie, S.H. Naik, N.D. Huntington, et al. 2016. Deciphering the innate lymphoid cell transcriptional program. Cell Reports. 17:436-447. http ://dx .doi .org/10 .1016/j .celrep .2016 .09 .025
51. Smith, P., C.M. Walsh, N.E. Mangan, R.E. Fallon, J.R. Sayers, A.N. McKenzie, and P.G. Fallon. 2004. Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J. Immunol. 173:1240-1248. http ://dx .doi .org/10 .4049/jimmunol .173 .2 .1240
52. Spits, H., and T. Cupedo. 2012. Innate lymphoid cells: emerging insights in development, lineage relationships, and function. Annu. Rev. Immunol. 30:647-675. http ://dx .doi .org/10 .1146/annurev-immunol-020711-075053
53. Subramanian, A., P. Tamayo, V.K. Mootha, S. Mukherjee, B.L. Ebert, M.A. Gillette, A. Paulovich, S.L. Pomeroy, T.R. Golub, E.S. Lander, and J.P. Mesirov. 2005. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. USA. 102:15545-15550. http ://dx .doi .org/10 .1073/pnas .0506580102
54. Terrazas, L.I., D. Montero, C.A. Terrazas, J.L. Reyes, and M. Rodríguez-Sosa. 2005. Role of the programmed Death-1 pathway in the suppressive activity of alternatively activated macrophages in experimental cysticercosis. Int. J. Parasitol. 35:1349-1358. http ://dx .doi .org/10 .1016/j .ijpara .2005 .06 .003
55. Topalian, S.L., F.S. Hodi, J.R. Brahmer, S.N. Gettinger, D.C. Smith, D.F. McDermott, J.D. Powderly, R.D. Carvajal, J.A. Sosman, M.B. Atkins, et al. 2012. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N. Engl. J. Med. 366:2443-2454. http ://dx .doi .org/10 .1056/NEJMoa1200690
56. + T cells leads to reversible immune dysfunction. Nat. Med. 12:1198-1202. http ://dx .doi .org/10 .1038/nm1482
57. Wang, S., and L. Chen. 2011. Immunobiology of cancer therapies targeting CD137 and B7-H1/PD-1 cosignal pathways. Curr. Top. Microbiol. Immunol. 344:245-267
58. Wang, Z., M. Medrzycki, S.T. Bunting, and K.D. Bunting. 2015. Stat5-deficient hematopoiesis is permissive for Myc-induced B-cell leukemogenesis. Oncotarget. 6:28961-28972
59. + T cell exhaustion during chronic viral infection. Immunity. 27:670-684. http ://dx .doi .org/10 .1016/j .immuni .2007 .09 .006
60. Yaqub, F. 2015. Nivolumab for squamous-cell non-small-cell lung cancer. Lancet Oncol. 16:e319. http ://dx .doi .org/10 .1016/S1470-2045(15)00033-9
61. Yin, H., X. Li, S. Hu, T. Liu, B. Yuan, Q. Ni, F. Lan, X. Luo, H. Gu, and F. Zheng. 2013. IL-33 promotes Staphylococcus aureus-infected wound healing in mice. Int. Immunopharmacol. 17:432-438. http ://dx .doi .org/10 .1016/j .intimp .2013 .07 .008
62. Yu, Y., J.C. Tsang, C. Wang, S. Clare, J. Wang, X. Chen, C. Brandt, L. Kane, L.S. Campos, L. Lu, et al. 2016. Single-cell RNA-seq identifies a PD-1(hi) ILC progenitor and defines its development pathway. Nature. 539:102-106. http ://dx .doi .org/10 .1038/nature20105